Skip to main content
Erschienen in: Digestive Diseases and Sciences 3/2017

23.11.2015 | Original Article

A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury

verfasst von: Lauren Heidemann, James Law, Robert J. Fontana

Erschienen in: Digestive Diseases and Sciences | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Idiosyncratic drug-induced liver injury (DILI) is an uncommon but important cause of liver disease that is challenging to diagnose and identify in the electronic medical record (EMR).

Aim

To develop an accurate, reliable, and efficient method of identifying patients with bonafide DILI in an EMR system.

Methods

In total, 527,000 outpatient and ER encounters in an EPIC-based EMR were searched for potential DILI cases attributed to eight drugs. A searching algorithm that extracted 200 characters of text around 14 liver injury terms in the EMR were extracted and collated. Physician investigators reviewed the data outputs and used standardized causality assessment methods to adjudicate the potential DILI cases.

Results

A total of 101 DILI cases were identified from the 2564 potential DILI cases that included 62 probable DILI cases, 25 possible DILI cases, nine historical DILI cases, and five allergy-only cases. Elimination of the term “liver disease” from the search strategy improved the search recall from 4 to 19 %, while inclusion of the four highest yield liver injury terms further improved the positive predictive value to 64 % but reduced the overall case detection rate by 47 %. RUCAM scores of the 57 probable DILI cases were generally high and concordant with expert opinion causality assessment scores.

Conclusions

A novel text searching tool was developed that identified a large number of DILI cases from a widely used EMR system. A computerized extraction of dictated text followed by the manual review of text snippets can rapidly identify bona fide cases of idiosyncratic DILI.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109:950–966.CrossRefPubMed Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109:950–966.CrossRefPubMed
2.
Zurück zum Zitat Fontana RJ, Hayashi PH, Gu J, Reddy KR, Barnhart H, On Behalf of the DILIN Network. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset. Gastroenterology. 2014;147:96–108.CrossRefPubMedPubMedCentral Fontana RJ, Hayashi PH, Gu J, Reddy KR, Barnhart H, On Behalf of the DILIN Network. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset. Gastroenterology. 2014;147:96–108.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008;135:1924–1934.CrossRefPubMedPubMedCentral Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008;135:1924–1934.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014;146:914–928.CrossRefPubMed Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014;146:914–928.CrossRefPubMed
5.
Zurück zum Zitat Bjornsson ES, Bergmann OM, Bjornsson HG, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144:1419–1425.CrossRefPubMed Bjornsson ES, Bergmann OM, Bjornsson HG, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144:1419–1425.CrossRefPubMed
6.
Zurück zum Zitat Hayashi PH, Fontana RJ. Clinical features, diagnosis, and natural history of drug induced liver injury. Semin Liv Dis. 2014;34:134–144.CrossRef Hayashi PH, Fontana RJ. Clinical features, diagnosis, and natural history of drug induced liver injury. Semin Liv Dis. 2014;34:134–144.CrossRef
7.
Zurück zum Zitat Garcia-Cortes M, Stephens C, Lucena MI, et al. Causality assessment methods in drug induced liver injury: strengths and weaknesses. J Hepatol. 2011;55:683–691.CrossRefPubMed Garcia-Cortes M, Stephens C, Lucena MI, et al. Causality assessment methods in drug induced liver injury: strengths and weaknesses. J Hepatol. 2011;55:683–691.CrossRefPubMed
8.
Zurück zum Zitat Meier Y, Cavallaro M, Roos M, Pauli-Magnus C, Folkers G, Meier PJ. Incidence of drug induced liver injury in medical inpatients. Eur J Clin Pharmacol. 2005;61:135–143.CrossRefPubMed Meier Y, Cavallaro M, Roos M, Pauli-Magnus C, Folkers G, Meier PJ. Incidence of drug induced liver injury in medical inpatients. Eur J Clin Pharmacol. 2005;61:135–143.CrossRefPubMed
9.
Zurück zum Zitat Duh MS, Walker AM, Kronlund KH. Descriptive epidemiology of acute liver enzyme abnormalities in the general population of central Massachusetts. Pharmacoepid Drug Saf. 1999;8:275–283.CrossRef Duh MS, Walker AM, Kronlund KH. Descriptive epidemiology of acute liver enzyme abnormalities in the general population of central Massachusetts. Pharmacoepid Drug Saf. 1999;8:275–283.CrossRef
10.
Zurück zum Zitat Jinjuvadia K, Kwan W, Fontana RJ. Searching for a needle in a haystack: use of ICD-9-CM codes in drug-induced liver injury. Am J Gastroenterol. 2007;102:2437–2443.CrossRefPubMed Jinjuvadia K, Kwan W, Fontana RJ. Searching for a needle in a haystack: use of ICD-9-CM codes in drug-induced liver injury. Am J Gastroenterol. 2007;102:2437–2443.CrossRefPubMed
11.
Zurück zum Zitat Overby CL, Pathak J, Gottesman O, et al. A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. J Am Med Inform Assoc. 2013;20:e243–e3252.CrossRefPubMedPubMedCentral Overby CL, Pathak J, Gottesman O, et al. A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. J Am Med Inform Assoc. 2013;20:e243–e3252.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Warrer P, Hansen EH, Juhl-Jensen L, et al. Using text-mining techniques in electronic patient records to identify ADRs from medicine use. Br J Clin Pharmacol. 2011;73:674–684.CrossRefPubMedCentral Warrer P, Hansen EH, Juhl-Jensen L, et al. Using text-mining techniques in electronic patient records to identify ADRs from medicine use. Br J Clin Pharmacol. 2011;73:674–684.CrossRefPubMedCentral
13.
Zurück zum Zitat Honigman B, Lee J, Rothschild J, et al. Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc. 2001;8:254–266.CrossRefPubMedPubMedCentral Honigman B, Lee J, Rothschild J, et al. Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc. 2001;8:254–266.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Field TS, Gurwitz JH, Harrold LR, et al. Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc. 2004;11:492–498.CrossRefPubMedPubMedCentral Field TS, Gurwitz JH, Harrold LR, et al. Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc. 2004;11:492–498.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Fontana RJ, Watkins PB, Bonkovsky HL, et al. Drug-induced liver injury network (DILIN) prospective study. Rational, design, and conduct. Drug Saf. 2009;32:55–68.CrossRefPubMedPubMedCentral Fontana RJ, Watkins PB, Bonkovsky HL, et al. Drug-induced liver injury network (DILIN) prospective study. Rational, design, and conduct. Drug Saf. 2009;32:55–68.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Danan G, Benichou C. Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol. 1993;46:1323–1330.CrossRefPubMed Danan G, Benichou C. Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol. 1993;46:1323–1330.CrossRefPubMed
18.
Zurück zum Zitat Fontana RJ, Seeff LB, Andrade RJ, et al. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology. 2010;52:730–742.CrossRefPubMedPubMedCentral Fontana RJ, Seeff LB, Andrade RJ, et al. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology. 2010;52:730–742.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Rochon J, Protiva P, Seeff LB, et al. Reliability of the Roussel Uclaf causality assessment method for assessing causality in drug-induced liver injury. Hepatology. 2008;48:1175–1183.CrossRefPubMedPubMedCentral Rochon J, Protiva P, Seeff LB, et al. Reliability of the Roussel Uclaf causality assessment method for assessing causality in drug-induced liver injury. Hepatology. 2008;48:1175–1183.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Rockey DC, Seeff LB, Rochon J, et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology. 2010;51:2117–2126.CrossRefPubMedPubMedCentral Rockey DC, Seeff LB, Rochon J, et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology. 2010;51:2117–2126.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Hayashi PH, Barnhart HX, Fontana RJ, et al. Reliability of causality assessment for drug, herbal, and dietary supplement hepatotoxicity in the drug induced liver injury network. Liv Int. 2015;35:1623–1632.CrossRef Hayashi PH, Barnhart HX, Fontana RJ, et al. Reliability of causality assessment for drug, herbal, and dietary supplement hepatotoxicity in the drug induced liver injury network. Liv Int. 2015;35:1623–1632.CrossRef
22.
Zurück zum Zitat Andrade RJ, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129:512–521.CrossRefPubMed Andrade RJ, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129:512–521.CrossRefPubMed
23.
Zurück zum Zitat Kleiner D, Chalasani N, Lee WML, et al. Hepatic histological findings in suspected drug-induced liver injury: systematic review and clinical associations. Hepatology. 2014;59:661–670.CrossRefPubMed Kleiner D, Chalasani N, Lee WML, et al. Hepatic histological findings in suspected drug-induced liver injury: systematic review and clinical associations. Hepatology. 2014;59:661–670.CrossRefPubMed
Metadaten
Titel
A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury
verfasst von
Lauren Heidemann
James Law
Robert J. Fontana
Publikationsdatum
23.11.2015
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 3/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3970-8

Weitere Artikel der Ausgabe 3/2017

Digestive Diseases and Sciences 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.